Trials / Conditions / Bacterial Keratitis

Bacterial Keratitis

14 registered clinical trials studyying Bacterial Keratitis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis NCT07394257	Minia University	N/A
Active Not Recruiting	Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II NCT06271772	University of California, San Francisco	Phase 3
Recruiting	Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis NCT06451172	Eye & ENT Hospital of Fudan University	EARLY_Phase 1
Completed	The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study NCT05655689	Alexandria University	—
Completed	Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Cornea NCT04213885	Eye Specialists of Indiana	Phase 2
Recruiting	Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking NCT03918408	Pacific Clear Vision Institute	Phase 1
Completed	Prospective, Randomized Multi-Center Study of Using the Hyper-CL™ Lens in Subjects Suffering From Bacterial Ke NCT03845374	Eye-yon Medical	N/A
Completed	Besifloxacin in Bacterial Keratitis NCT02497365	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
Terminated	Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Random NCT02088970	Nantes University Hospital	N/A
Unknown	Matrix Therapy And Bacterial Keratitis NCT02016989	University Hospital, Clermont-Ferrand	N/A
Completed	Collagen Cross-linking in Infectious Keratitis Trial NCT01831206	Chulalongkorn University	Phase 2
Completed	Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients NCT00707005	Yonsei University	—
Completed	Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal NCT00651586	Allergan	Phase 2
Completed	A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers NCT00386958	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 2